We share our Insights on a regular basis.

Media Contacts

Terra Liddell: Chief Marketing Officer; Washington, DC; Email

Angela Robinson: Director of Branding and Communications; Washington, DC; Email

IP Updates

Unified Patent Court (UPC) Hub

2026

Articles

Preempting Surprise Injunctions in Germany and the UPC: Strategic Use of the Schutzschrift in Global Patent Litigation

March 27, 2026

Articles

Patent Ruling Shows Quiet Power of State-Law Bad-Faith Statutes

February 20, 2026

Articles

EPR Academy, Part 2 of 6: The EPR Process – From Request to Reexamination Certificate

December 5, 2025

IP Updates

Tenth Circuit Sides with Netflix in Tiger King Copyright Challenge

May 5, 2026

IP Updates

PIER Pilot Program - Synopsis

IP Updates

White House Releases National AI Legislative Framework

March 23, 2026

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Federal Circuit IP Blog

Federal Circuit Affirms § 102(b) Invalidity; Source Code Commands Are Not Hearsay

May 14, 2026

INCONTESTABLE® Blog

Supreme Court Recalibrates Contributory Copyright Liability

March 30, 2026

Recent Insights

Downloadable Media

Event Type

Hosting Organization

Finnegan-Hosted

Workshop

Protecting Innovation in the Life Sciences: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law Protecting Innovation in the Life Sciences: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law

May 7, 2026

Cambridge

European IP Blog

T 0137/24 and Securing Effective Protection for Biologics T 0137/24 and Securing Effective Protection for Biologics

1 May 2026

European IP Blog

Precision Breeding in England: Navigating the New Regulatory Framework Precision Breeding in England: Navigating the New Regulatory Framework

9 December 2025

Articles

EPO Referral May Shift Patent Description Amendment Rules EPO Referral May Shift Patent Description Amendment Rules

November 4, 2025

Law360

European IP Blog

Colour Drawings at the EPO: What You Need to Know Colour Drawings at the EPO: What You Need to Know

1 October 2025

European IP Blog

Description Amendments in the Spotlight – A Referral to the Enlarged Board in G 1/25 Description Amendments in the Spotlight – A Referral to the Enlarged Board in G 1/25

7 August 2025

Seminar

Basel: Life Sciences IP Seminar: Multijurisdictional Considerations for Protecting Your Most Valuable Assets Basel: Life Sciences IP Seminar: Multijurisdictional Considerations for Protecting Your Most Valuable Assets

May 16, 2024

Basel

Seminar

Copenhagen: Life Sciences IP Seminar: Multijurisdictional Considerations for Protecting Your Most Valuable Assets Copenhagen: Life Sciences IP Seminar: Multijurisdictional Considerations for Protecting Your Most Valuable Assets

May 14, 2024

Copenhagen

Workshop

Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law

May 2, 2024

Cambridge

Webinar

Navigating Your Life Sciences Opposition: Tips for Best Practice When You Are Opposing or Opposed Navigating Your Life Sciences Opposition: Tips for Best Practice When You Are Opposing or Opposed

December 12, 2023

Webinar

European IP Blog

The EPO’s “10 Day Notification Period” Comes to an End The EPO’s “10 Day Notification Period” Comes to an End

11 October 2023

European IP Blog

The Implausibility of “Plausibility” as an Evidentiary Standard at the EPO The Implausibility of “Plausibility” as an Evidentiary Standard at the EPO

March 24, 2023